Why Choose Us for Neuroblastoma Care?

Comer Children's Hospital at the University of Chicago offers a depth of neuroblastoma resources that is unmatched in the Chicago area.

Susan Cohn, MD, is an internationally known neuroblastoma expert.

Nationally Recognized Experts in Neuroblastoma

Our program team is led by one of the nation's leading authorities on neuroblastoma. Additionally, team members hold leadership positions in national pediatric cooperative clinical research organizations including the Neuroblastoma Disease Committee of the Children's Oncology Group and the Neuroblastoma Research Association.

The Newest Treatment Options

Phase 1 clinical trials make available the very newest drug therapies for children with advanced disease. Comer Children's Hospital is one of only 14 hospitals in the United States that can offer phase 1 trials to children with neuroblastoma.

One of the Best Cancer Centers in the U.S.

With outstanding resources and personnel dedicated to cancer research and treatment, the cancer program of the University of Chicago Medical Center is consistently ranked among the 10 best in the nation by U.S.News & World Report, which has published its respected listings of America's "Best Hospitals" since 1990.

Neuroblastoma expert Sam Volchenboum, MD, PhD, had his head shaved in solidarity with pediatric cancer patients at a 2009 St. Baldrick's Foundation event. Volchenboum was awarded a St. Baldrick's grant to support his research into using real-time proteomics to distinguish types of neuroblastoma. »Learn more about this important neuroblastoma research

Experts in Analyzing Neuroblastoma

As the hub of the Children's Oncology Group's Risk Tracking Center for Neuroblastoma, the doctors at Comer Children's Hospital are experts in identifying clinical, pathologic, and biologic features that are critical for risk-group assignment and appropriate treatment planning.

Phase 3 Clinical Trials of New Anti-Cancer Therapies

Through our membership in the Children's Oncology Group, patients here have access to many promising new treatments that are being evaluated at leading cancer programs throughout North America.

Expertise in High-Risk, Aggressive Forms of Neuroblastoma

Our team has the expertise and experience to address advanced, difficult-to-treat forms of this disease.

Unique Clinical Trial Protocols for Older Teens

Collaboration between the adult and pediatric cancer programs at the University of Chicago Medical Center expands treatment options for older teens who have neuroblastoma. Beginning at age 14, teens may be eligible to participate in clinical trials of new anti-cancer drugs currently under investigation for adults with other types of cancer. Comer Children's Hospital has special approval to allow older teens into these adult-focused clinical trials.

Ground-Level Research

In addition to testing the effectiveness of new treatments through clinical trials, physicians and scientists here also conduct research in the lab. With close cooperation between research and patient care activities, discoveries made in the lab can be translated into clinical advances that may improve treatment options for neuroblastoma.

More Information

» Neuroblastoma Care Program
» Why Choose Us For Neuroblastoma Care?